Table 3.
Data from a review of all six- to nine-month multi-centre registries or clinical trials of single Co-Cr stent types with more 100 patients (MEDLINE search results extend to 31 May 2013; table excludes studies restricted to patients presenting only with STEMI)
| Registry | Stent name | Material | Strut thickness (μm) | Number of patients | Average stent length (mm) | Average stent diameter (mm) | Presenting conditions | Follow-up (months) | Delivery success | MACE | TLR/TVRa |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MULTIBENE [22] | PRO-Kinetik | SiC-coated L605 | 60–120 | 198 | 15.7 ± 3 .5 | 3.21 ± 0.45 | No AMI | 6 | – | 11.4 % | 7.6 % |
| Arthos Pico Austrian Multicentre [23] | Arthos Pico | Phynox Co-Cr | 65 | 203 | 16.2 ± 6.5 | 2.58 ± 0.22 | Real-world | 6 | 98.0 % | 13.0 % | 6.0 % |
| SOLSTICE | SolarFlex | L605 Co-Cr | 65 | 240 | 17.5 ± 4.82 | 3.15 ± 0.38 | Real-world | 6 | 100 % | 5.8 % | 5.0 % |
| CoroFlex Blue registry [24] | CoroFlex Blue | L605 Co-Cr | 65 | 2315 | 15.6 ± 4.4 | 3.01 ± 0.43 | Real-world | 6 | 98.5 % | 9.2 % | 5.5 % |
| MILES [25] | Skylor | L605 Co-Cr | 70–95 | 1020 | 19.5 ± 10.3 | 3.03 ± 0.43 | Real-world | 6+ | 98 % | 9.9 % | 5.0 % |
| VISION registry [17] | Vision | L605 Co-Cr | 81 | 267 | 17.2 ± 6.3 | 3.34 ± 0.37 | No AMI | 6 | 100 % | 6.2 % | 4.3 % |
| VIVE [16] | Vision | L605 Co-Cr | 81 | 429 | – | – | Real-world | 6 | 99.3 % | 6.8 % | 1.4 % |
| RISICO [18] | Vision | L605 Co-Cr | 81 | 143 | 17.0 ± 3.9 | 2.41 ± 0.14 | No AMI | 6 | 96.7 % | 11.6 % | 5.8 % |
| Driver registry [26] | Driver | MP35N Co-Cr | 91 | 298 | – | – | Real-world | 9 | 100 % | 8.4 % | 7.0 % |
| CLASS [27] | Driver | MP35N Co-Cr | 91 | 202 | – | – | No AMI | 6 | 100 % | 12.4 % | 9.4 % |
aWhere available as an endpoint, cTLR data were been used preferentially for comparison purposes